CLINICAL ROLE -
Solving the Puzzle of Persistent HIV Replication
Research explores how HIV is able to evolve during antiretroviral therapy.
Read More
Multiple Myeloma Drug Recommended for Approval in Europe
Empliciti is an immunostimulatory antibody that targets the Signaling Lymphocyte Activation Molecule Family member 7.
Near-Infrared Laser May Enhance Cancer Immunotherapy
Optogenetics technique harnesses immune system to reduce tumor size and metastasis.
Lowest Premium Marketplace Health Plans Not Always Most Cost Effective for HIV Patients
Study finds the greatest access to cost-sharing reduction subsidies translated to the lowest costs for patients with HIV.
Specialty Connect Program Found to Improve Drug Adherence
CVS program indicates option of in-store pickup or home delivery improved adherence rates.
USP Updates Standards that Protect Health Care Workers from Hazardous Drugs
Updated guidelines seek to decrease the risk of residual exposure to potentially dangerous medications.
Nanoparticles Show Promise in Liver Cancer Treatment
Treatment delivers miRNA to late-stage liver cancer tumors with low toxicity.
Experimental Painkiller Could Match Strength of Morphine Without Addiction
Engineered variants of neurochemical endomorphin could potentially relieve pain without causing drug addiction.
Should Medicare Cover the Cost of Obesity Treatment?
Obesity-related chronic diseases are a primary driver of higher costs in the Medicare system.
Grace and Dignity in the Shadow of ALS
A patient discusses her courageous battle with familial amyotrophic lateral sclerosis.
Pregnant Women Face Greater Melanoma Risk
Women diagnosed with malignant melanoma during pregnancy or within 1 year of giving birth were 5.1 times as likely to die.
Enhanced Screening in Prisons Could Reduce Spread of Hepatitis C
Study indicates nearly 12,000 deaths related to the liver could be prevented from routine HCV screenings.
Smart Pill May Improve Treatment of Intestinal Disorders
Intestinal gases colon cancer, irritable bowel syndrome, and inflammatory bowel disease.
EGFR Inhibitor Improves Survival in Lung Cancer Patients with Brain Metastases
Afatinib showed significant improvement in progression-free survival and objective response rate in non-small cell lung cancer patients.
Neuroblastoma Immunotherapy Improves Overall Survival
Dinutuximab is the first immunotherapy approved for the treatment of a pediatric cancer.
What is the Optimal Time Between Chemotherapy and Cancer Surgery?
Researchers seek to determine the ideal duration between radiation treatment and the actual surgical removal of cancerous cells.
Food Preservative Shows Cancer Killing Properties
Nisin shows promise in killing cancer and deadly bacteria resistant to antibiotics.
FDA Approves New Formulation of Acid Reflux Disease Treatment
Dexilant SoluTab is a delayed-release orally disintegrating tablet that treats heartburn associated with GERD.
Researchers Push for Patient-Controlled Health Care Data
Personally-controlled health records have been prevented from adoption due to provider-based electronic health records.
Epilepsy Drug May Help Reduce Disability from Multiple Sclerosis
Findings may lead to new treatment that protects nerves from damage caused in optic neuritis and throughout the central nervous system during MS attacks.
Researchers Predict Which Colon Cancer Patients Will Benefit from Chemotherapy
Newly identified biomarker may help determine whether patients will need chemotherapy post-surgery.
Lymphoma Treatment Market Poised for Massive Growth
Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.
Medical Marijuana Shows Promise Reducing Migraine Frequency
Study is the first to show a decrease in migraine frequency from medical marijuana.
Top 10 Prescription Drugs by Total Spending
Sovaldi tops the list of highest total annual drug spending by user.
FDA Approves New Liposarcoma Therapy
Halaven treats liposarcoma patients who received prior chemotherapy that contained an anthracycline drug.
Venetoclax Granted Breakthrough Designation for Acute Myeloid Leukemia
Venetoclax is an inhibitor of the B-cell lymphoma-2 protein in previously untreated AML patients.
Prostate Cancer Drug Granted Breakthrough Therapy Designation
Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.